首页> 外文期刊>African Journal of Microbiology Research >Anti-biofilm activity of ibuprofen and diclofenac against some biofilm producing Escherichia coli and Klebsiella pneumoniae uropathogens
【24h】

Anti-biofilm activity of ibuprofen and diclofenac against some biofilm producing Escherichia coli and Klebsiella pneumoniae uropathogens

机译:布洛芬和双氯芬酸对某些产生生物膜的大肠杆菌和肺炎克雷伯菌肺炎病原菌的抗生物膜活性

获取原文
获取外文期刊封面目录资料

摘要

Ibuprofen (IBU) and Diclofenac (DIC) are non-steroidal anti-inflammatory drug which have shown to have broad antimicrobial activity and limit biofilm formation. Aim of this study was to evaluate the effects of IBU and DIC against biofilm formation strong strains Escherichia coli and Klebsiella pneumoniae associated with urinary tract infections (UTIs). Additionally some virulence factors, antibiotic resistance, ESBL production were estimated to find correlation with the biofilm production and acil homoserine lactone (AHL). Our results suggest that IBU and DIC, could be useful in the treatment of urinary tract infections caused by E. coli and K. pneumoniae. IBU with CMIB 8, 30 and 125 mg/L, caused dramatic reductions in some cases and inhibited virulence factors which changes in the morphotypes expressed on congo red agar. DIC with CMIB 30 and 50 mg/L caused reductions in biofilm formation 50.1%. In this study, were evidenced the relationship between virulence factors, production of AHL and multi drugs resistance with biofilm production.
机译:布洛芬(IBU)和双氯芬酸(DIC)是非甾体类抗炎药,已显示出广泛的抗菌活性并限制了生物膜的形成。这项研究的目的是评估IBU和DIC对与尿路感染(UTIs)相关的强生物膜形成菌株大肠杆菌和肺炎克雷伯菌的作用。另外,估计一些毒力因子,抗生素抗性,ESBL产生与生物膜产生和高丝丝氨酸内酯(AHL)相关。我们的结果表明,IBU和DIC可用于治疗由大肠杆菌和肺炎克雷伯菌引起的尿路感染。具有CMIB 8、30和125 mg / L的IBU在某些情况下引起显着降低,并抑制了毒力因子,这些因子改变了刚果红琼脂上表达的形态。含CMIB 30和50 mg / L的DIC导致生物膜形成减少50.1%。在这项研究中,证明了毒力因子,AHL的产生和生物膜产生的多重耐药性之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号